Canada issues final rules on classifying products as drugs, devices

03/18/2013 | Clinica (subscription required)

Health Canada has finalized guidelines for classifying therapeutic products as drugs or devices. The guidance sheds light on the considerations for determining whether a product is a medical device or drug, and it aims to promote a standardized and transparent process when deciding the appropriate regulatory pathway. The guidance notes that a product cannot be considered both a device and a drug.

View Full Article in:

Clinica (subscription required)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN